Akihiro Abe Selected Research

Akihiro Abe Research Topics

Disease

11	Leukemia 03/2016 - 04/2003
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 12/2008
6	Neoplasms (Cancer) 01/2020 - 08/2006
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2018 - 03/2010
2	Philadelphia Chromosome 09/2018 - 03/2010
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2014 - 10/2012
2	Lymphoma (Lymphomas) 12/2014 - 10/2012
2	Hematologic Neoplasms (Hematological Malignancy) 11/2012 - 09/2012
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2010 - 08/2006
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2008 - 07/2007
1	Acute Promyelocytic Leukemia 12/2022
1	Anemia 07/2021
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020
1	Chickenpox 12/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2014
1	Herpes Zoster 12/2014
1	Blast Crisis (Blast Phase) 01/2013
1	Lymphopenia (Lymphocytopenia) 10/2012
1	Hepatitis 10/2012
1	Varicella Zoster Virus Infection 10/2012
1	Infections 10/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2012
1	Genetic Translocation (Chromosomal Translocation) 08/2012
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2012
1	Choriocarcinoma 02/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2006
1	Abdominal Obesity 04/2006
1	Primitive Neuroectodermal Tumors (PNET) 10/2004
1	Thyroid Neoplasms (Thyroid Cancer) 10/2004
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 10/2004

Drug/Important Bio-Agent (IBA)

7	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 12/2008
5	Phosphotransferases (Kinase)IBA 01/2020 - 11/2006
3	Tyrosine Kinase InhibitorsIBA 09/2018 - 11/2010
3	Transcription Factors (Transcription Factor)IBA 03/2016 - 10/2010
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 03/2016
2	Immunoglobulin G (IgG)IBA 12/2014 - 10/2012
2	Rituximab (Mabthera)FDA Link 12/2014 - 10/2012
2	Proteins (Proteins, Gene)FDA Link 09/2012 - 10/2010
2	Etoposide (VP 16)FDA LinkGeneric 10/2004 - 04/2003
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 12/2022
1	Hemoglobins (Hemoglobin)IBA 07/2021
1	AZD5991IBA 01/2020
1	Granulocyte Colony-Stimulating Factor Receptors (G-CSF Receptor)IBA 01/2020
1	venetoclaxIBA 01/2020
1	ponatinibIBA 01/2020
1	Chemokine CXCL12IBA 03/2016
1	Acyclovir (Aciclovir)FDA LinkGeneric 12/2014
1	Neutralizing AntibodiesIBA 12/2014
1	AntibodiesIBA 12/2014
1	nilotinib FDA Link 01/2014
1	Prednisolone (Predate)FDA LinkGeneric 10/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2012
1	Vincristine (Oncovin)FDA LinkGeneric 10/2012
1	Antisense RNA (Anti-Sense RNA)IBA 08/2012
1	Peptides (Polypeptides)IBA 03/2012
1	HLA-B51 AntigenIBA 03/2012
1	HydrocarbonsIBA 10/2010
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2010
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2010
1	KW 2449IBA 08/2009
1	Histones (Histone)IBA 08/2009
1	Aurora KinasesIBA 08/2009
1	Collagen Type I (Type I Collagen)IBA 02/2009
1	Small Interfering RNA (siRNA)IBA 02/2009
1	Extracellular Matrix ProteinsIBA 02/2009
1	Fibronectins (Fibronectin)IBA 02/2009
1	Integrin alpha5beta1IBA 02/2009
1	Integrin beta1IBA 02/2009
1	NucleophosminIBA 01/2009
1	Retinoic Acid Receptor alphaIBA 01/2009
1	bcr-abl Fusion ProteinsIBA 12/2008
1	Antineoplastic Agents (Antineoplastics)IBA 09/2008
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2008
1	Histone Deacetylase InhibitorsIBA 09/2008
1	beta CateninIBA 02/2008
1	E-SelectinIBA 07/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2006
1	Peroxidase (Myeloperoxidase)IBA 08/2006
1	C-Reactive ProteinIBA 04/2006
1	CholesterolIBA 04/2006
1	Glucose (Dextrose)FDA LinkGeneric 04/2006
1	Cytochromes c (Cytochrome c)IBA 10/2004
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 10/2004
1	LigandsIBA 04/2003
1	Troglitazone (Rezulin)FDA Link 04/2003
1	PPAR gammaIBA 04/2003

Therapy/Procedure

4	Therapeutics 04/2014 - 08/2006
2	Drug Therapy (Chemotherapy) 12/2014 - 10/2012
1	Hematopoietic Stem Cell Transplantation 10/2012
1	Molecular Targeted Therapy 09/2012
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2012
1	Oral Administration 08/2009
1	Heterologous Transplantation (Xenotransplantation) 08/2006
1	Subcutaneous Injections 08/2006